TG THERAPEUTICS INC (TGTX) Stock Cash Flow
NASDAQ:TGTX - Nasdaq - US88322Q1085 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -14.36M | 12.67M | -198.34M | -348.10M | -279.38M | |||
| Depreciation Amortization | 100.00K | 211.00K | 300.00K | 280.00K | 160.00K | |||
| Change In Working Capital | -56.40M | -84.45M | -1.44M | -12.00M | -19.54M | |||
| Interest Paid | 14.48M | 8.77M | 5.45M | 3.47M | 4.50M | |||
| Other non cash items | 42.57M | 40.15M | 23.30M | 64.19M | 84.26M | |||
| OPERATING CASH FLOW | -28.09M | -31.41M | -176.17M | -295.63M | -214.51M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -10.00K | -400.00K | -360.00K | |||
| Other Investing Activity | -61.55M | -50.65M | -20.00M | 70.00K | -24.15M | |||
| INVESTING CASH FLOW | -61.58M | -50.65M | -20.01M | -330.00K | -24.51M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 137.26M | 25.00M | -980.00K | 40.00M | 0.00 | |||
| Stock Issued/Repurchased | -1.80M | 47.83M | 580.00K | 2.44M | 679.83M | |||
| Other Financing Activity | -853.00K | -125.00K | 0.00 | -1.02M | 0.00 | |||
| FINANCING CASH FLOW | 134.59M | 72.70M | -390.00K | 41.42M | 679.83M | |||
| CHANGE IN CASH | 44.93M | -9.36M | -196.57M | -254.54M | 440.81M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -28.09M | -31.41M | -176.17M | -295.63M | -214.51M | |||
| Capital Expenditure | N/A | 0.00 | -10.00K | -400.00K | -360.00K | |||
| FREE CASH FLOW | -28.11M | -31.41M | -176.18M | -296.03M | -214.87M | |||
All data in USD